Our team has been dedicated to achieving several objectives to advance our product and bring it to fruition. We have made significant progress in both the development and validation of this technology, as well as initiating steps to commercialize and communicate about our product.We've focused on developing RemmedVR technology, a vision therapy solution using VR,which progressed significantly. We identified a substantial opportunity within the field of neurodiagnostics, particularly for neurological and neurodegenerative disorders. The resulting product, NeuroScreen VR, is a groundbreaking solution that leverages eye-tracking technology to provide invaluable data about a patient's neurological function.By tracking eye movements,NeuroScreen VR offers a non-invasive method to gather and analyze neurological biomarkers, thus enabling early detection and monitoring of various neurological conditions.The hardware and software development for NeuroScreen VR was thoroughly carried out, ensuring optimal design efficiency and ergonomic user comfort. The software development phase included creating an application compatible with VR headsets, constructing various neurological function tests, and developing modern data analysis algorithms.A comprehensive system documentation was also prepared, detailing all stages of development and testing.We conducted scientific studies and trials with partner clinics across Europe and the US to ensure our VR products meet market demands and contribute to improved patient outcomes. We evaluated the effectiveness of Remmed VR solution in treating anisometropic amblyopia.The study found a significantly positive attitude towards VR rehabilitation compared to occlusion, suggesting the potential of VR technology as a supportive treatment protocol for anisometropic amblyopia.We also conducted thorough market research and competition analysis, engaged with key opinion leaders, and assessed the potential impact of the new NeuroScreen VR system.We also defined a comprehensive commercialization strategy, including pricing strategies, distribution channels, marketing, and promotional activities.Safety assessments, particularly eye-safety calculations regarding irradiance,were also performed to ensure the system's compliance with safety regulations and standards.We implemented a communication strategy that involved press releases, project website, social media and event organization.In summary, despite facing challenges and complexities,we have achieved considerable progress in the development,validation, commercialization, and communication of our technology,a promising tool that stands to contribute significantly to the fields of neurodiagnostics.
